Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Aurobindo Pharma enters US inhalation market with generic Advair launch

The launch marks Aurobindo Pharma's entry into the US inhalation market and expands its complex generics portfolio beyond conventional oral solid formulations

Aurobindo Pharma enters US inhalation market with generic Advair launch

We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.

Read the original at business-standard.com →

More in Finance & Markets

More from Monday 31 August →